Glenmark Investigational Site 22 — Saginaw, Michigan

Glenmark Investigational Site 22 is a clinical research site located in Saginaw, Michigan, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Glenmark Investigational Site 22 has participated in 1 clinical trials.

Therapeutic areas: Osteoarthritis.

Sponsors: Glenmark Pharmaceuticals Ltd. India.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Glenmark Investigational Site 22?

Glenmark Investigational Site 22 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Glenmark Investigational Site 22 conducted?

Glenmark Investigational Site 22 has 1 clinical trials on record. Their work covers Osteoarthritis.

Is Glenmark Investigational Site 22 accredited by Crixeo Health?

Glenmark Investigational Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Glenmark Investigational Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.